Global Typhoid Vi Polysaccharide Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Typhoid Vi Polysaccharide Vaccine market size was valued at US$ 512.6 million in 2023. With growing demand in downstream market, the Typhoid Vi Polysaccharide Vaccine is forecast to a readjusted size of US$ 735.4 million by 2030 with a CAGR of 5.3% during review period.
The research report highlights the growth potential of the global Typhoid Vi Polysaccharide Vaccine market. Typhoid Vi Polysaccharide Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Typhoid Vi Polysaccharide Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Typhoid Vi Polysaccharide Vaccine market.
Typhoid Vi polysaccharide vaccine is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Typhoid Vi Polysaccharide Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Typhoid Vi Polysaccharide Vaccine market. It may include historical data, market segmentation by Type (e.g., Child, Adult), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Typhoid Vi Polysaccharide Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Typhoid Vi Polysaccharide Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Typhoid Vi Polysaccharide Vaccine industry. This include advancements in Typhoid Vi Polysaccharide Vaccine technology, Typhoid Vi Polysaccharide Vaccine new entrants, Typhoid Vi Polysaccharide Vaccine new investment, and other innovations that are shaping the future of Typhoid Vi Polysaccharide Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Typhoid Vi Polysaccharide Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Typhoid Vi Polysaccharide Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Typhoid Vi Polysaccharide Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Typhoid Vi Polysaccharide Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Typhoid Vi Polysaccharide Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Typhoid Vi Polysaccharide Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Typhoid Vi Polysaccharide Vaccine market.
Market Segmentation:
Typhoid Vi Polysaccharide Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Typhoid Vi Polysaccharide Vaccine market?
What factors are driving Typhoid Vi Polysaccharide Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Typhoid Vi Polysaccharide Vaccine market opportunities vary by end market size?
How does Typhoid Vi Polysaccharide Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global Typhoid Vi Polysaccharide Vaccine market size was valued at US$ 512.6 million in 2023. With growing demand in downstream market, the Typhoid Vi Polysaccharide Vaccine is forecast to a readjusted size of US$ 735.4 million by 2030 with a CAGR of 5.3% during review period.
The research report highlights the growth potential of the global Typhoid Vi Polysaccharide Vaccine market. Typhoid Vi Polysaccharide Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Typhoid Vi Polysaccharide Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Typhoid Vi Polysaccharide Vaccine market.
Typhoid Vi polysaccharide vaccine is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Typhoid Vi Polysaccharide Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Typhoid Vi Polysaccharide Vaccine market. It may include historical data, market segmentation by Type (e.g., Child, Adult), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Typhoid Vi Polysaccharide Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Typhoid Vi Polysaccharide Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Typhoid Vi Polysaccharide Vaccine industry. This include advancements in Typhoid Vi Polysaccharide Vaccine technology, Typhoid Vi Polysaccharide Vaccine new entrants, Typhoid Vi Polysaccharide Vaccine new investment, and other innovations that are shaping the future of Typhoid Vi Polysaccharide Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Typhoid Vi Polysaccharide Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Typhoid Vi Polysaccharide Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Typhoid Vi Polysaccharide Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Typhoid Vi Polysaccharide Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Typhoid Vi Polysaccharide Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Typhoid Vi Polysaccharide Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Typhoid Vi Polysaccharide Vaccine market.
Market Segmentation:
Typhoid Vi Polysaccharide Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Child
- Adult
- Government Institution
- Private Sector
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi Pasteur SA
- GSK
- Emergent BioSolutions
What is the 10-year outlook for the global Typhoid Vi Polysaccharide Vaccine market?
What factors are driving Typhoid Vi Polysaccharide Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Typhoid Vi Polysaccharide Vaccine market opportunities vary by end market size?
How does Typhoid Vi Polysaccharide Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Typhoid Vi Polysaccharide Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Typhoid Vi Polysaccharide Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Typhoid Vi Polysaccharide Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Typhoid Vi Polysaccharide Vaccine Segment by Type
2.2.1 Child
2.2.2 Adult
2.3 Typhoid Vi Polysaccharide Vaccine Sales by Type
2.3.1 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Typhoid Vi Polysaccharide Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Typhoid Vi Polysaccharide Vaccine Sale Price by Type (2019-2024)
2.4 Typhoid Vi Polysaccharide Vaccine Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Typhoid Vi Polysaccharide Vaccine Sales by Application
2.5.1 Global Typhoid Vi Polysaccharide Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Typhoid Vi Polysaccharide Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Typhoid Vi Polysaccharide Vaccine Sale Price by Application (2019-2024)
3 GLOBAL TYPHOID VI POLYSACCHARIDE VACCINE BY COMPANY
3.1 Global Typhoid Vi Polysaccharide Vaccine Breakdown Data by Company
3.1.1 Global Typhoid Vi Polysaccharide Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Typhoid Vi Polysaccharide Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Company (2019-2024)
3.2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Typhoid Vi Polysaccharide Vaccine Sale Price by Company
3.4 Key Manufacturers Typhoid Vi Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Typhoid Vi Polysaccharide Vaccine Product Location Distribution
3.4.2 Players Typhoid Vi Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TYPHOID VI POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Typhoid Vi Polysaccharide Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Typhoid Vi Polysaccharide Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Typhoid Vi Polysaccharide Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Typhoid Vi Polysaccharide Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Typhoid Vi Polysaccharide Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Typhoid Vi Polysaccharide Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Typhoid Vi Polysaccharide Vaccine Sales Growth
4.4 APAC Typhoid Vi Polysaccharide Vaccine Sales Growth
4.5 Europe Typhoid Vi Polysaccharide Vaccine Sales Growth
4.6 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Growth
5 AMERICAS
5.1 Americas Typhoid Vi Polysaccharide Vaccine Sales by Country
5.1.1 Americas Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024)
5.1.2 Americas Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024)
5.2 Americas Typhoid Vi Polysaccharide Vaccine Sales by Type
5.3 Americas Typhoid Vi Polysaccharide Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Typhoid Vi Polysaccharide Vaccine Sales by Region
6.1.1 APAC Typhoid Vi Polysaccharide Vaccine Sales by Region (2019-2024)
6.1.2 APAC Typhoid Vi Polysaccharide Vaccine Revenue by Region (2019-2024)
6.2 APAC Typhoid Vi Polysaccharide Vaccine Sales by Type
6.3 APAC Typhoid Vi Polysaccharide Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Typhoid Vi Polysaccharide Vaccine by Country
7.1.1 Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024)
7.1.2 Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024)
7.2 Europe Typhoid Vi Polysaccharide Vaccine Sales by Type
7.3 Europe Typhoid Vi Polysaccharide Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Typhoid Vi Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Type
8.3 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Typhoid Vi Polysaccharide Vaccine
10.3 Manufacturing Process Analysis of Typhoid Vi Polysaccharide Vaccine
10.4 Industry Chain Structure of Typhoid Vi Polysaccharide Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Typhoid Vi Polysaccharide Vaccine Distributors
11.3 Typhoid Vi Polysaccharide Vaccine Customer
12 WORLD FORECAST REVIEW FOR TYPHOID VI POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
12.1 Global Typhoid Vi Polysaccharide Vaccine Market Size Forecast by Region
12.1.1 Global Typhoid Vi Polysaccharide Vaccine Forecast by Region (2025-2030)
12.1.2 Global Typhoid Vi Polysaccharide Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Typhoid Vi Polysaccharide Vaccine Forecast by Type
12.7 Global Typhoid Vi Polysaccharide Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur SA
13.1.1 Sanofi Pasteur SA Company Information
13.1.2 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sanofi Pasteur SA Main Business Overview
13.1.5 Sanofi Pasteur SA Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Typhoid Vi Polysaccharide Vaccine Product Portfolios and Specifications
13.2.3 GSK Typhoid Vi Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Emergent BioSolutions
13.3.1 Emergent BioSolutions Company Information
13.3.2 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product Portfolios and Specifications
13.3.3 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Emergent BioSolutions Main Business Overview
13.3.5 Emergent BioSolutions Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Typhoid Vi Polysaccharide Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Typhoid Vi Polysaccharide Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Typhoid Vi Polysaccharide Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Typhoid Vi Polysaccharide Vaccine Segment by Type
2.2.1 Child
2.2.2 Adult
2.3 Typhoid Vi Polysaccharide Vaccine Sales by Type
2.3.1 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Typhoid Vi Polysaccharide Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Typhoid Vi Polysaccharide Vaccine Sale Price by Type (2019-2024)
2.4 Typhoid Vi Polysaccharide Vaccine Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Typhoid Vi Polysaccharide Vaccine Sales by Application
2.5.1 Global Typhoid Vi Polysaccharide Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Typhoid Vi Polysaccharide Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Typhoid Vi Polysaccharide Vaccine Sale Price by Application (2019-2024)
3 GLOBAL TYPHOID VI POLYSACCHARIDE VACCINE BY COMPANY
3.1 Global Typhoid Vi Polysaccharide Vaccine Breakdown Data by Company
3.1.1 Global Typhoid Vi Polysaccharide Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Typhoid Vi Polysaccharide Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Company (2019-2024)
3.2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Typhoid Vi Polysaccharide Vaccine Sale Price by Company
3.4 Key Manufacturers Typhoid Vi Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Typhoid Vi Polysaccharide Vaccine Product Location Distribution
3.4.2 Players Typhoid Vi Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TYPHOID VI POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Typhoid Vi Polysaccharide Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Typhoid Vi Polysaccharide Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Typhoid Vi Polysaccharide Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Typhoid Vi Polysaccharide Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Typhoid Vi Polysaccharide Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Typhoid Vi Polysaccharide Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Typhoid Vi Polysaccharide Vaccine Sales Growth
4.4 APAC Typhoid Vi Polysaccharide Vaccine Sales Growth
4.5 Europe Typhoid Vi Polysaccharide Vaccine Sales Growth
4.6 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Growth
5 AMERICAS
5.1 Americas Typhoid Vi Polysaccharide Vaccine Sales by Country
5.1.1 Americas Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024)
5.1.2 Americas Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024)
5.2 Americas Typhoid Vi Polysaccharide Vaccine Sales by Type
5.3 Americas Typhoid Vi Polysaccharide Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Typhoid Vi Polysaccharide Vaccine Sales by Region
6.1.1 APAC Typhoid Vi Polysaccharide Vaccine Sales by Region (2019-2024)
6.1.2 APAC Typhoid Vi Polysaccharide Vaccine Revenue by Region (2019-2024)
6.2 APAC Typhoid Vi Polysaccharide Vaccine Sales by Type
6.3 APAC Typhoid Vi Polysaccharide Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Typhoid Vi Polysaccharide Vaccine by Country
7.1.1 Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024)
7.1.2 Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024)
7.2 Europe Typhoid Vi Polysaccharide Vaccine Sales by Type
7.3 Europe Typhoid Vi Polysaccharide Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Typhoid Vi Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Type
8.3 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Typhoid Vi Polysaccharide Vaccine
10.3 Manufacturing Process Analysis of Typhoid Vi Polysaccharide Vaccine
10.4 Industry Chain Structure of Typhoid Vi Polysaccharide Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Typhoid Vi Polysaccharide Vaccine Distributors
11.3 Typhoid Vi Polysaccharide Vaccine Customer
12 WORLD FORECAST REVIEW FOR TYPHOID VI POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
12.1 Global Typhoid Vi Polysaccharide Vaccine Market Size Forecast by Region
12.1.1 Global Typhoid Vi Polysaccharide Vaccine Forecast by Region (2025-2030)
12.1.2 Global Typhoid Vi Polysaccharide Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Typhoid Vi Polysaccharide Vaccine Forecast by Type
12.7 Global Typhoid Vi Polysaccharide Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur SA
13.1.1 Sanofi Pasteur SA Company Information
13.1.2 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sanofi Pasteur SA Main Business Overview
13.1.5 Sanofi Pasteur SA Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Typhoid Vi Polysaccharide Vaccine Product Portfolios and Specifications
13.2.3 GSK Typhoid Vi Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Emergent BioSolutions
13.3.1 Emergent BioSolutions Company Information
13.3.2 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product Portfolios and Specifications
13.3.3 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Emergent BioSolutions Main Business Overview
13.3.5 Emergent BioSolutions Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Typhoid Vi Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Typhoid Vi Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Child
Table 4. Major Players of Adult
Table 5. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Typhoid Vi Polysaccharide Vaccine Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2019-2024)
Table 13. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Typhoid Vi Polysaccharide Vaccine Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Typhoid Vi Polysaccharide Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Typhoid Vi Polysaccharide Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Typhoid Vi Polysaccharide Vaccine Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Typhoid Vi Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 21. Players Typhoid Vi Polysaccharide Vaccine Products Offered
Table 22. Typhoid Vi Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Typhoid Vi Polysaccharide Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Typhoid Vi Polysaccharide Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Typhoid Vi Polysaccharide Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Typhoid Vi Polysaccharide Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas Typhoid Vi Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Typhoid Vi Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Typhoid Vi Polysaccharide Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC Typhoid Vi Polysaccharide Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC Typhoid Vi Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Typhoid Vi Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe Typhoid Vi Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Typhoid Vi Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Typhoid Vi Polysaccharide Vaccine
Table 58. Key Market Challenges & Risks of Typhoid Vi Polysaccharide Vaccine
Table 59. Key Industry Trends of Typhoid Vi Polysaccharide Vaccine
Table 60. Typhoid Vi Polysaccharide Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Typhoid Vi Polysaccharide Vaccine Distributors List
Table 63. Typhoid Vi Polysaccharide Vaccine Customer List
Table 64. Global Typhoid Vi Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Typhoid Vi Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Typhoid Vi Polysaccharide Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Typhoid Vi Polysaccharide Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Sanofi Pasteur SA Basic Information, Typhoid Vi Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Portfolios and Specifications
Table 80. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Sanofi Pasteur SA Main Business
Table 82. Sanofi Pasteur SA Latest Developments
Table 83. GSK Basic Information, Typhoid Vi Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Typhoid Vi Polysaccharide Vaccine Product Portfolios and Specifications
Table 85. GSK Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. Emergent BioSolutions Basic Information, Typhoid Vi Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product Portfolios and Specifications
Table 90. Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Emergent BioSolutions Main Business
Table 92. Emergent BioSolutions Latest Developments
Table 1. Typhoid Vi Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Typhoid Vi Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Child
Table 4. Major Players of Adult
Table 5. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Typhoid Vi Polysaccharide Vaccine Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2019-2024)
Table 13. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Typhoid Vi Polysaccharide Vaccine Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Typhoid Vi Polysaccharide Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Typhoid Vi Polysaccharide Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Typhoid Vi Polysaccharide Vaccine Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Typhoid Vi Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 21. Players Typhoid Vi Polysaccharide Vaccine Products Offered
Table 22. Typhoid Vi Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Typhoid Vi Polysaccharide Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Typhoid Vi Polysaccharide Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Typhoid Vi Polysaccharide Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Typhoid Vi Polysaccharide Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas Typhoid Vi Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Typhoid Vi Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Typhoid Vi Polysaccharide Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC Typhoid Vi Polysaccharide Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC Typhoid Vi Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Typhoid Vi Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe Typhoid Vi Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Typhoid Vi Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Typhoid Vi Polysaccharide Vaccine
Table 58. Key Market Challenges & Risks of Typhoid Vi Polysaccharide Vaccine
Table 59. Key Industry Trends of Typhoid Vi Polysaccharide Vaccine
Table 60. Typhoid Vi Polysaccharide Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Typhoid Vi Polysaccharide Vaccine Distributors List
Table 63. Typhoid Vi Polysaccharide Vaccine Customer List
Table 64. Global Typhoid Vi Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Typhoid Vi Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Typhoid Vi Polysaccharide Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Typhoid Vi Polysaccharide Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Sanofi Pasteur SA Basic Information, Typhoid Vi Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Portfolios and Specifications
Table 80. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Sanofi Pasteur SA Main Business
Table 82. Sanofi Pasteur SA Latest Developments
Table 83. GSK Basic Information, Typhoid Vi Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Typhoid Vi Polysaccharide Vaccine Product Portfolios and Specifications
Table 85. GSK Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. Emergent BioSolutions Basic Information, Typhoid Vi Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product Portfolios and Specifications
Table 90. Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Emergent BioSolutions Main Business
Table 92. Emergent BioSolutions Latest Developments
LIST OF FIGURES
Figure 1. Picture of Typhoid Vi Polysaccharide Vaccine
Figure 2. Typhoid Vi Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Typhoid Vi Polysaccharide Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Typhoid Vi Polysaccharide Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Child
Figure 10. Product Picture of Adult
Figure 11. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type in 2023
Figure 12. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. Typhoid Vi Polysaccharide Vaccine Consumed in Government Institution
Figure 14. Global Typhoid Vi Polysaccharide Vaccine Market: Government Institution (2019-2024) & (K Units)
Figure 15. Typhoid Vi Polysaccharide Vaccine Consumed in Private Sector
Figure 16. Global Typhoid Vi Polysaccharide Vaccine Market: Private Sector (2019-2024) & (K Units)
Figure 17. Typhoid Vi Polysaccharide Vaccine Consumed in Other
Figure 18. Global Typhoid Vi Polysaccharide Vaccine Market: Other (2019-2024) & (K Units)
Figure 19. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2023)
Figure 20. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application in 2023
Figure 21. Typhoid Vi Polysaccharide Vaccine Sales Market by Company in 2023 (K Units)
Figure 22. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Company in 2023
Figure 23. Typhoid Vi Polysaccharide Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Typhoid Vi Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas Typhoid Vi Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Typhoid Vi Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC Typhoid Vi Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Typhoid Vi Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe Typhoid Vi Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country in 2023
Figure 37. Americas Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Regions in 2023
Figure 45. APAC Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country in 2023
Figure 56. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Typhoid Vi Polysaccharide Vaccine in 2023
Figure 73. Manufacturing Process Analysis of Typhoid Vi Polysaccharide Vaccine
Figure 74. Industry Chain Structure of Typhoid Vi Polysaccharide Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Typhoid Vi Polysaccharide Vaccine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Typhoid Vi Polysaccharide Vaccine
Figure 2. Typhoid Vi Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Typhoid Vi Polysaccharide Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Typhoid Vi Polysaccharide Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Child
Figure 10. Product Picture of Adult
Figure 11. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type in 2023
Figure 12. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. Typhoid Vi Polysaccharide Vaccine Consumed in Government Institution
Figure 14. Global Typhoid Vi Polysaccharide Vaccine Market: Government Institution (2019-2024) & (K Units)
Figure 15. Typhoid Vi Polysaccharide Vaccine Consumed in Private Sector
Figure 16. Global Typhoid Vi Polysaccharide Vaccine Market: Private Sector (2019-2024) & (K Units)
Figure 17. Typhoid Vi Polysaccharide Vaccine Consumed in Other
Figure 18. Global Typhoid Vi Polysaccharide Vaccine Market: Other (2019-2024) & (K Units)
Figure 19. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2023)
Figure 20. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application in 2023
Figure 21. Typhoid Vi Polysaccharide Vaccine Sales Market by Company in 2023 (K Units)
Figure 22. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Company in 2023
Figure 23. Typhoid Vi Polysaccharide Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Typhoid Vi Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas Typhoid Vi Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Typhoid Vi Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC Typhoid Vi Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Typhoid Vi Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe Typhoid Vi Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country in 2023
Figure 37. Americas Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Regions in 2023
Figure 45. APAC Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country in 2023
Figure 56. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Typhoid Vi Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Typhoid Vi Polysaccharide Vaccine in 2023
Figure 73. Manufacturing Process Analysis of Typhoid Vi Polysaccharide Vaccine
Figure 74. Industry Chain Structure of Typhoid Vi Polysaccharide Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Typhoid Vi Polysaccharide Vaccine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Clinical Biomarkers Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
October 2024
110 pages
Global Endoscope Market Growth 2026-2032
US$ 3,660.00
January 2025
139 pages
Global Breathing Filters Market Growth 2025-2031
US$ 3,660.00
March 2025
122 pages
Global Emergency Hemostatic Agent Market Growth 2023-2029
US$ 3,660.00
March 2023
113 pages
Global Vessel Dilators Market Growth 2024-2030
US$ 3,660.00
June 2024
94 pages
